- Home
- LXRX vs BTQ Comparison
LXRX vs BTQ Comparison
Compare LXRX & BTQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXRX | BTQ |
|---|---|---|
| Founded | 1995 | 1983 |
| Country | United States | Canada |
| Employees | N/A | 35 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 990.6M | 831.4M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LXRX | BTQ |
|---|---|---|
| Price | $2.34 | $3.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $4.15 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 2.7M | 1.9M |
| Earning Date | 05-01-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | $2,332.99 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $1.02 | $2.09 |
| 52 Week High | $2.68 | $16.00 |
Technical Indicators
Market Signals| Indicator | LXRX | BTQ |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 36.51 |
| Support Level | $2.04 | $3.12 |
| Resistance Level | $2.61 | $3.42 |
| Average True Range (ATR) | 0.15 | 0.26 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 65.12 | 5.68 |
Price Performance
Historical ComparisonAbout LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
About BTQ BTQ Technologies Corp.
BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. The company derives revenue from Software licensing. Geographically, the company has a presence in Canada, Taiwan, Australia, and the United States.